- ROUNDTABLE: Pharmacy’s future in sync with technology
- Study from NCPA sheds new light on med synchronization programs
- EXPERT BLOG: Provider status for pharmacists — one way or another
- Senate passes Drug Quality and Security Act
- Coalition of healthcare industry stakeholders address best practices regarding controlled substances
ALEXANDRIA, Va. — Following the release of U.S. Pharmacopeia's Proposed General Chapter Prescription Container Labeling recommendations, the National Association of Chain Drug Stores issued a letter to USP urging flexibility and an open dialogue with pharmacy and prescriber communities as review of the recommendations continues.
"The chain pharmacy industry shares the goal of providing prescription container labels that are useful for patients. Our members have devoted significant resources and time to developing prescription container labels that are designed to provide patients with the useful information that they need to take their medications as prescribed," NACDS stated in its comment letter.
In the letter, NACDS addressed concerns with some of the recommendations, including technological issues, cost concerns, legal restrictions, prescriber requirements, container and label size limitations, as well as linguistic challenges.
NACDS also highlighted the role of pharmacy in delivering medication therapy management services, which can improve medication adherence. Poor medication adherence costs the United States approximately $290 billion annually — 13% of total healthcare expenditures. Providing concise, understandable prescription container labeling can further assist patients in adhering to their medication regimens to improve health and reduce costs.
"We ask USP to consider outreach and further interaction with prescribers, pharmacies and pharmacists for further discussion, and to develop a greater understanding of the issues for pharmacies," the letter stated.